iQtech LLC, a Qatar-based startup specializing in advanced medical simulation and XR technologies, has successfully closed its first investment round. The funding marks a critical transition for the company as it moves from its founding vision in 2025 to a structured and funded entity. The round saw participation from Selexi, a European leader in computer-based testing and assessment, and Yuniro, a deep-tech company operating between Italy and Qatar.
Accelerating the Future of Medical Training
The capital injection is earmarked to accelerate the development of EsculapioVR, the company’s flagship AI-powered medical training and assessment platform. By merging realistic virtual reality (VR) simulations with AI-driven evaluation, EsculapioVR aims to transform traditional medical education and operational performance. The startup plans to utilize the investment to strengthen its infrastructure and expand its footprint across Qatar and the wider MENA region.
Ecosystem Support and Strategic Growth
iQtech LLC developed its platform within the Qatar Science & Technology Park (QSTP) ecosystem, crediting the hub’s guidance and incubator support as fundamental to its successful funding milestone. The participation of Selexi and Yuniro brings not only capital but also significant technical expertise in assessment and automation. This first investment round serves as a foundational step in iQtech’s journey to modernize healthtech and edutech solutions through immersive XR technologies.
About iQtech LLC
Founded in 2025 and based in Doha, Qatar, iQtech LLC is an innovative tech startup focused on HealthTech and EduTech. The company specializes in developing advanced medical simulation systems and cross-reality (XR) technologies. Its core mission is to bridge the gap between education and operational excellence by creating high-fidelity, AI-enhanced training platforms that cater to the medical, civil, and military sectors.
Source: iQtech LLC
